Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system by Miguel Betancourt-Cravioto, Patricia Cervantes-Powell, Roberto Tapia-Conyer, Shaleesa Ledlie, Sonja Gandhi-Banga

Get full text

Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season by Sonja Gandhi-Banga, Anne-Laure Chabanon, Cecile Eymin, Timothy Caroe, Karina Butler, Annick Moureau

Get full text

Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza sea... by Marina Amaral de Avila Machado, Sonja Gandhi-Banga, Sophie Gallo, Tathyana Giannotti Cousseau, Reddappa Maniganahally Byrareddy, Markku Nissilä, Jörg Schelling, Celine Monfredo

Get full text

Safety of quadrivalent recombinant influenza vaccine in pregnant persons and their infantsAJOG Global Reports at a Glance by Amber Hsiao, PhD, MPH, Arnold Yee, MBA, Ruvim Izikson, MD, MPH, Bruce Fireman, MA, John Hansen, MPH, Ned Lewis, MPH, Sonja Gandhi-Banga, PhD, Alexandre Selmani, PhD, Oxana Talanova, MD, MPH, Heidi Kabler, MD, Ajinkya Inamdar, MBBS, MS, MBA, Nicola P. Klein, MD, PhD

Get full text